CD4 and neoplasm: Furthermore, gene transfer of CIITA into tumor cells resulted in a stimulation of tumor specific CD4+ T cells in vivo associated with a long-lasting protective immunity [34], as well as an increased repertoire of tumor-associated HLA class II antigens [35].